Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes
Cancer Medicine · 2025
DOI: 10.1002/cam4.70577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Jackson N Howell und 15 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms, Anxiety Disorders, Mental Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, CDC HHS, Huntsman Cancer Foundation.
Abstract (Originalsprache)
Background
We investigated mental health diagnoses (MHDs) in mycosis fungoides (MF) patients compared to the general population, evaluated risk factors, and studied survival outcomes in a large population database.
Methods
MF patients from the Utah Cancer Registry diagnosed from 2001 to 2014 were matched with up to five general population individuals from the Utah Population Database. MHDs were retrospectively tracked in both populations (median follow‐up = 6.67 years). Risk factors for new MHDs among MF patients were studied using the Cox proportional hazards model. Overall survival (OS) and disease‐specific survival (DSS) were assessed using Kaplan–Meier analysis.
Results
The incidence of anxiety disorders (HR = 1.99, 95% CI [1.16, 3.42]) and delirium/dementia disorders (HR = 2.43, 95% CI [1.05, 5.63]) was higher among MF patients than the matched general population. Among MF patients, Charlson Comorbidity Index (CCI) ≥ 2 and BMI < 18 kg/m 2 were risk factors for new anxiety disorders. Radiation therapy, CCI ≥ 2, and female gender were risk factors for new delirium/dementia disorders. The 15‐year OS was worse for MF patients with versus without an MHD (36% vs. 81%, HR 2.62, 95%CI [1.24, 5.65]). The 15‐year DSS also worsened for MF patients with versus without an MHD (63% vs. 97%, HR 6.55, 95%CI [1.64, 26.2]).
Conclusions
MF patients developed anxiety and delirium/dementia disorders at rates above the general population, and MHDs correlated with worse DSS and OS. Careful mental health monitoring may be an actionable step towards improving health‐related quality of life in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Huntsman Cancer Institute, Salt Lake City, Utah, USA.
- Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
- Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
- Department of Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.
ORCID-Profile: Jackson N Howell, Shane L Lloyd, Michael J LaRiviere
Förderung
- NCI NIH HHS
- CDC HHS
- Huntsman Cancer Foundation
- National Cancer Institute
- Centers for Disease Control and Prevention
Zitieren
APA
Howell, J. N., Mark, B., Wada, D. A., Bowling, M., Wei, M., Lloyd, S. L., Gaffney, D. K., Maity, A., LaRiviere, M. J., Rule, W. G., Grant, J. D., Deshmukh, V., Newman, M., Date, A., Hashibe, M., & Tao, R. (2025). Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer Medicine. https://doi.org/10.1002/cam4.70577
Vancouver
Howell JN, Mark B, Wada DA, Bowling M, Wei M, Lloyd SL, et al. Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer Medicine. 2025. doi:10.1002/cam4.70577
BibTeX
@article{Howell2025,
author = {Howell, Jackson N and Mark, Bayarmaa and Wada, David A and Bowling, Marianne and Wei, Mei and Lloyd, Shane L and Gaffney, David K and Maity, Amit and LaRiviere, Michael J and Rule, William G and Grant, Jon D and Deshmukh, Vikrant and Newman, Michael and Date, Ankita and Hashibe, Mia and Tao, Randa},
title = {Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70577}
}
EUVIMED